CT |
computed tomography |
DAB |
3,3′-diaminobenzidine |
DIILD |
drug-induced interstitial lung disease |
ECM |
extracellular matrix |
FDG |
fludeoxyglucose |
FOV |
field of view |
HRCT |
high resolution computed tomography |
H&E |
hematoxylin and Eosin |
IBs |
imaging biomarkers |
IL |
interleukin |
ILD |
interstitial lung disease |
IPF |
idiopathic pulmonary fibrosis |
i.t. |
intratracheal |
LBIC |
Lund university BioImaging Centre |
LOX |
Lysyl Oxidase |
MMPs |
Matrix metallopeptidases |
MRI |
magnetic resonance imaging |
PET |
positron emission tomography |
ROI |
region of interest |
TGF-β |
tissue growth factor β |
TIMP1 |
tissue inhibitor of metalloproteinase 1 |
TRISTAN-IMI |
Translational Imaging in Drug Safety Assessment—Innovative Medicines Initiative |
UTE |
ultra short echo time |